Self-Renewal and Cancers of the Gastric Epithelium: An Update and the Role of the Lectin TFF1 as an Antral Tumor Suppressor

Int J Mol Sci. 2022 May 11;23(10):5377. doi: 10.3390/ijms23105377.

Abstract

In 2020, gastric cancer was the fourth leading cause of cancer deaths globally. About 90% of gastric cancers are sporadic and the vast majority are correlated with Helicobacter pylori infection; whereas familial clustering is observed in about 10% of cases. Gastric cancer is now considered to be a disease originating from dysregulated self-renewal of the gastric glands in the setting of an inflammatory environment. The human stomach contains two types of gastric units, which show bi-directional self-renewal from a complex variety of stem cells. This review focuses on recent progress concerning the characterization of the different stem cell populations and the mainly mesenchymal signals triggering their stepwise differentiation as well as the genesis of pre-cancerous lesions and carcinogenesis. Furthermore, a model is presented (Lectin-triggered Receptor Blocking Hypothesis) explaining the role of the lectin TFF1 as an antral tumor suppressor possibly regulating Lgr5+ antral stem cells in a paracrine or maybe autocrine fashion, with neighboring antral gland cells having a role as niche cells.

Keywords: cell differentiation; gastric cancer; gastric mucosa; gastric self-renewal; lectin; metaplasia; stem cell; stomach; telocyte; trefoil factor.

Publication types

  • Review

MeSH terms

  • Epithelium / pathology
  • Gastric Mucosa / pathology
  • Helicobacter Infections* / pathology
  • Helicobacter pylori*
  • Humans
  • Lectins
  • Stomach Neoplasms* / pathology
  • Trefoil Factor-1

Substances

  • Lectins
  • TFF1 protein, human
  • Trefoil Factor-1

Grants and funding

This research received no external funding.